Reasons for blood donation deferral in sub-Saharan Africa: experience in Ivory Coast

Maxime Diane Kouao1, Bamory Dembelé, Landry Kouassi N'Goran

  • 1General Hospital at Yopougon Attié, Ivory Coast. dianekouao@yahoo.fr

Transfusion
|July 12, 2012
PubMed

Insights

Low hemoglobin and sexual behavior are key reasons for blood donor deferral in Ivory Coast. These deferrals, though similar in rate to high-middle income countries, highlight preventable issues through targeted donor education.

Area of Science:

  • Transfusion Medicine
  • Public Health
  • Hematology

Background:

  • Donor selection is critical for blood transfusion safety.
  • Data on blood donor deferral reasons in Ivory Coast is limited.
  • Understanding deferral patterns is essential for optimizing blood supply.

Purpose of the Study:

  • To identify and analyze the primary reasons for predonation deferral.
  • To provide insights into blood donor demographics and deferral causes in Abidjan.

Main Methods:

  • Retrospective audit of blood donor records.
  • Data collected from January 2006 to December 2008.
  • Analysis of donor deferral reasons at General Hospital, Yopougon Attié.

Main Results:

  • 10,694 prospective donors were evaluated; 2618 (10.8%) were deferred.
  • Low hemoglobin levels were the most common deferral reason (42.5%), predominantly in females.
  • New or changed sexual partners accounted for 34.3% of deferrals, mainly in males.
  • Other deferral reasons included short interdonation intervals (4.6%) and biomarker reactivity (2.3%).

Conclusions:

  • Deferral rates in Ivory Coast are comparable to high-middle income countries, but causes and demographics differ.
  • Preventable factors, such as low hemoglobin and sexual behavior, contribute significantly to deferrals.
  • Awareness campaigns and education can mitigate deferral causes and improve donor pool health.
Abstract

Related Concept Videos

Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
The ABO Blood Group01:12

The ABO Blood Group

The ABO blood group system is a critical element of transfusion medicine, essential for determining blood compatibility in transfusions and organ transplants. It is based on specific antigens, or agglutinogens, present on the surface of red blood cells (RBCs) and corresponding antibodies, or agglutinins, in the blood plasma.
Antigens in the ABO Blood Group System
Antigens are substances that can trigger an immune response, leading to the production of antibodies. In the ABO blood group system,...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Ethics in Research01:56

Ethics in Research

Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.